Weight-loss drugs show unexpected connection to cancer, researchers say
GLP-1 medications like Ozempic and Wegovy may reduce cancer risk linked to obesity, but the AACR's 2026 report says evidence is mixed and more research is needed.
Open original source
No comments yet.